Attributes 249% Revenue Growth to Portfolio Momentum and Focused ExecutionCORAL GABLES, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback